Dow Jones

44,556.04

0.30%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Misceláneo
LSE
Inter-amer 30 (BC43)
Inter-amer 30 (BC43) Noticias

BC43

Inter-amer 30 (BC43)

Inter-amer 30

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:BC43

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/11/2002	08:09	UK Regulatory	Rebecca O. Kendall Announces Retirement; Robert A. Armitage Promoted to Lilly Senior Vice President, General Counsel	LSE:BC43	Inter-amer 30
09/11/2002	03:30	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
08/11/2002	06:30	UK Regulatory	Lilly Outlines to Wall Street Its Strategy To Realize Its Growth Opportunities and Deliver Superior Earnings Growth Over the Lon	LSE:BC43	Inter-amer 30
29/10/2002	08:00	UK Regulatory	Cymbalta Data Suggest Rapid and Sustained Response by First Week of Therapy	LSE:BC43	Inter-amer 30
23/10/2002	07:10	UK Regulatory	3rd Quarter Results	LSE:BC43	Inter-amer 30
22/10/2002	02:01	UK Regulatory	Alimta Continues To Show Versatility in Treating Different Cancers	LSE:BC43	Inter-amer 30
21/10/2002	15:15	UK Regulatory	Dividend Declaration	LSE:BC43	Inter-amer 30
18/10/2002	02:00	UK Regulatory	Combining Innovative Therapies for Optimal Cancer Care; Effectiveness of Gemzar-Based Combination Regimens is Topic of Workshop	LSE:BC43	Inter-amer 30
01/10/2002	09:10	UK Regulatory	Newly Published Study Demonstrates Sustained Efficacy of Evista -raloxifene HCl- in Reducing Risk of Spinal Fractures	LSE:BC43	Inter-amer 30
25/09/2002	16:59	UK Regulatory	Lilly Asserts The New England Journal of Medicine ``Sounding Board'' Opinion Article Attempts to Turn Back the Clock on Care of	LSE:BC43	Inter-amer 30
24/09/2002	16:39	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
20/09/2002	08:07	UK Regulatory	Statement re	LSE:BC43	Inter-amer 30
17/09/2002	09:34	UK Regulatory	Lilly Launches World's Largest Severe Sepsis Clinical Trial; 11,000 Patients to be Enrolled in Study of Xigris Use in Patients w	LSE:BC43	Inter-amer 30
16/09/2002	12:02	UK Regulatory	FDA Issues Approvable Letter for Lilly's Cymbalta for Treatment of Depression; From the Makers of Prozac, Cymbalta Will Offer Ne	LSE:BC43	Inter-amer 30
16/09/2002	09:04	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
03/09/2002	09:08	UK Regulatory	Tadalafil for the Treatment of Erectile Dysfunction Receives Positive Recommendation From the Australian Drug Evaluation Committ	LSE:BC43	Inter-amer 30
26/08/2002	14:11	UK Regulatory	Regulatory Approval	LSE:BC43	Inter-amer 30
14/08/2002	08:29	UK Regulatory	FDA Issues Approvable Letter for Strattera for ADHD; Strattera Would Give Patients, Families and Physicians a New Treatment Opti	LSE:BC43	Inter-amer 30
01/08/2002	02:23	UK Regulatory	Lilly's Xigris Becomes First and Only Medical Product Approved for BIPA Payment in Medicare Patients	LSE:BC43	Inter-amer 30
25/07/2002	15:03	UK Regulatory	Lilly ICOS LLC	LSE:BC43	Inter-amer 30
30/04/2002	10:55	UK Regulatory	Financial Expectations-Update	LSE:BC43	Inter-amer 30
16/04/2002	04:25	UK Regulatory	Dividend	LSE:BC43	Inter-amer 30
15/04/2002	10:35	UK Regulatory	1st Quarter Results	LSE:BC43	Inter-amer 30
15/04/2002	02:00	RNS Non-Regulatory	Collaboration Extended	LSE:BC43	Lilly (Eli) & Co
25/03/2002	05:13	UK Regulatory	Annual Report and Accts etc	LSE:BC43	Inter-amer 30
20/03/2002	09:08	RNS Non-Regulatory	Translational Medicine Award	LSE:BC43	Lilly (Eli) & Co
20/03/2002	01:00	UK Regulatory	Research Update	LSE:BC43	Inter-amer 30
12/03/2002	12:07	RNS Non-Regulatory	Patient Assistance Program	LSE:BC43	Lilly (Eli) & Co
05/03/2002	03:08	UK Regulatory	2002 Xigris Sales	LSE:BC43	Inter-amer 30
20/02/2002	01:05	UK Regulatory	Directorate Change	LSE:BC43	Inter-amer 30